Theranexus (EPA:ALTHX)

PRESS RELEASE

published on 04/28/2026 at 19:00, 6 months 3 days ago

THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
THX Pharma announces annual results, cash position, and strategic partnerships, including Biocodex agreement. Financial stability secured. Focus on clinical development and commercialization of TX01 and Batten-1

Strategic Partnership Financial Stability Neurological Diseases THX Pharma Biocodex
BRIEF

published on 03/25/2026 at 18:50, 7 months 7 days ago

Theranexus publishes its letter to shareholders

Shareholders Biopharmaceutical Neurology Theranexus Drugs
BRIEF

published on 03/25/2026 at 18:50, 7 months 7 days ago

THX Pharma Publishes Letter to Shareholders

Innovation Shareholders Licensing Agreements Neurological Diseases THX Pharma
PRESS RELEASE

published on 03/25/2026 at 18:45, 7 months 7 days ago

THX Pharma Announces the Publication of its Letter to Shareholders
THX Pharma (Theranexus) announces the publication of a letter to shareholders regarding its innovative treatments for rare neurological diseases. Company details and contact information included

Shareholders Biopharmaceutical Theranexus Neurological Diseases THX Pharma
BRIEF

published on 02/25/2026 at 18:05, 8 months 4 days ago

THX Pharma increases the resources of its liquidity contract

Liquidity Contract Euronext Growth Biopharmaceutical Financial Resources THX Pharma
BRIEF

published on 02/19/2026 at 18:05, 8 months 10 days ago

THX Pharma Announces Strong Cash Position at Year-End

Cash Position THX Pharma Biocodex Agreement Batten-1 Program TX01 Development
BRIEF

published on 02/19/2026 at 18:05, 8 months 10 days ago

THX Pharma strengthens its financial position as of December 31, 2025

Treasury Partnership Batten-1 TX01 Biocodex
PRESS RELEASE

published on 02/19/2026 at 18:00, 8 months 10 days ago

THX Pharma Reports Its Cash Position as of December 31, 2025
THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development

Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement
BRIEF

published on 02/12/2026 at 18:05, 8 months 17 days ago

THX Pharma Announces Webinar on Strategic Agreement with Biocodex

Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
BRIEF

published on 02/12/2026 at 18:05, 8 months 17 days ago

THX Pharma and Biocodex conclude a major strategic agreement

Webinar Strategic Agreement THX Pharma Neurological Medications Biocodex

Published on 10/30/2026 at 23:35, 2 days 4 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 4 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 7 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 9 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 12 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/01/2026 at 10:35, 17 hours 43 minutes ago

Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 23 hours 18 minutes ago

2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 11 hours ago

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 5 hours ago

EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 22:30, 2 days 5 hours ago

/C O R R E C T I O N - OCI Global/

View all EQS

Published on 10/30/2026 at 23:00, 2 days 5 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 7 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 10 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 16 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 19 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News